Sanofi-Aventis (France) to Build C$100M R&D Facility in Canada

TORONTO, April 15 (Reuters) - The vaccines division of global biotechnology company Sanofi-Aventis said on Tuesday it will spend C$100 million to build a new research facility in North Toronto, focusing on pediatric and cancer treatments.